Medicare Enrolled

Dr. Rosemarie Lajara, MD

Endocrinology · Plano, TX
Speaking/Promotional
1708 COIT RD, Plano, TX 75075
8322373500
In practice since 2008 (18 years)
NPI: 1780862102 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lajara from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lajara? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lajara

Dr. Rosemarie Lajara is an endocrinology in Plano, TX, with 18 years in practice.

Between the years covered by Open Payments, Dr. Lajara received a total of $1,304,667 from 50 pharmaceutical and/or device companies across 2458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lajara is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice$ $1,304,667 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$1,304,667
Total received (2018-2024)
Avg $186,381/year across 7 years
Top 1% in TX for endocrinology
50
Companies
2,458
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,243,934 (95.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$45,046 (3.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,688 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$126,202
2023
$140,758
2022
$210,665
2021
$155,310
2020
$118,948
2019
$225,228
2018
$327,557

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$551,514
Novo Nordisk Inc
$248,011
Boehringer Ingelheim Pharmaceuticals, Inc.
$115,133
Abbott Laboratories
$114,898
SANOFI-AVENTIS U.S. LLC
$94,328
AstraZeneca Pharmaceuticals LP
$93,837
Valeritas, Inc.
$23,694
Eli Lilly and Company
$20,574
MannKind Corporation
$10,410
Mannkind Corporation
$5,697
Zealand Pharma US, Inc.
$5,228
Corcept Therapeutics
$4,519
Amarin Pharma Inc.
$4,485
Tandem Diabetes Care, Inc.
$3,033
IBSA Pharma Inc.
$2,064
Medtronic, Inc.
$2,023
Insulet Corporation
$1,356
CeQur Corporation
$384
Gilead Sciences, Inc.
$360
Dexcom, Inc.
$355
Merck Sharp & Dohme Corporation
$314
GRT US Holding, Inc.
$246
Xeris Pharmaceuticals, Inc.
$225
Radius Health, Inc.
$181
Intuity Medical Inc
$158
Medtronic MiniMed, Inc.
$150
DEXCOM, INC.
$136
Bayer HealthCare Pharmaceuticals Inc.
$134
Amgen Inc.
$133
Averitas Pharma Inc.
$121
Janssen Pharmaceuticals, Inc
$121
AbbVie Inc.
$118
BETA BIONICS, INC.
$117
ABBVIE INC.
$98
RECORDATI_RARE_DISEASES_INC.
$58
Sequel Med Tech, LLC
$55
Companion Medical, Inc.
$53
Ultragenyx Pharmaceutical Inc.
$46
Ascendis Pharma Inc
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$42
PFIZER INC.
$38
Itamar Medical Inc
$30
Amphastar Pharmaceuticals, Inc.
$26
Verity Pharmaceuticals Inc.
$26
Ascensia Diabetes Care Us Inc.
$24
KVK-Tech, Inc.
$18
Senseonics, Incorporated
$15
Ascensia Diabetes Care US Inc.
$15
Eisai Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 70.1% of total payments
Associated products mentioned in payments ›
ADLYXIN · AFREZZA · BAQSIMI · BASAGLAR · BYDUREON · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · Edarbi · Eversense · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LICART · LYUMJEV · MINIMED 780G · MOUNJARO · Minimed 670G System · NO PRODUCT DISCUSSED · Omnipod · Ozempic · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · QUTENZA · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SOTAGLIFLOZIN · SYNJARDY · SYNTHROID · Saxenda · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · WatchPATONE · Wegovy · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for endocrinology in TX.

Looking for a endocrinology in Plano?
Compare endocrinologys in the Plano area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
92
Per 100K population
8.2
County median income
$117,588
Nearest hospital
MEDICAL CITY PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lajara is a endocrinology, and high industry engagement (speaking/promotional, top 1%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Lajara receive payments from pharmaceutical companies?
Yes. Dr. Lajara received a total of $1,304,667 from 50 companies across 2,458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Lajara) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →